Attached files
| file | filename |
|---|---|
| 10-K - 10-K - SPECTRUM PHARMACEUTICALS INC | d856294d10k.htm |
| EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INC | d856294dex312.htm |
| EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INC | d856294dex311.htm |
| EX-21.1 - EX-21.1 - SPECTRUM PHARMACEUTICALS INC | d856294dex211.htm |
| EX-32.1 - EX-32.1 - SPECTRUM PHARMACEUTICALS INC | d856294dex321.htm |
| EX-23.1 - EX-23.1 - SPECTRUM PHARMACEUTICALS INC | d856294dex231.htm |
| EX-32.2 - EX-32.2 - SPECTRUM PHARMACEUTICALS INC | d856294dex322.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SPECTRUM PHARMACEUTICALS INC | Financial_Report.xls |
EXHIBIT 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-150260, 333-142628, 333-135029, 333-125208, 333-121612, 333-115759, 333-110103, 333-108658, 333-105814, 333-102587, 333-64444, 333-64432, 333-60966, 333-51388, 333-42852, 333-38710, 333-37180, 333-92855, 333-73009, 333-52331, 333-37585, 333-185115, 333-190413, 333-194823; and Form S-8 Nos. 333-176681, 333-160312, 333-160705, 333-164014, 333-134566, 333-119833, 333-106427, 333-54246, 333-30345) of Spectrum Pharmaceuticals, Inc. and in the related Prospectuses of our report dated March 12, 2014, with respect to the consolidated financial statements and schedule of Spectrum Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
| /s/ Ernst & Young LLP |
| Irvine, California |
| March 13, 2015 |